ArticleComputational and structural biotechnology journal2025
MSF-CPMP: A novel multi-source feature fusion model for prediction of cyclic peptide membrane permeability.
Article in Computational and structural biotechnology journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cyclic peptides are becoming attractive molecules for drug discovery because of their properties with inherent stability and structural diversity. However, the high potential of cyclic peptide drugs is challenged by the limited membrane permeability cross cell membrane. To predict cyclic peptide membrane permeability (CPMP), an increased number of computational models or tools are designed and used. But these existing algorithms or models do not appropriately capture feature diversity of cyclic peptides. In this study, we introduce a novel multi-source feature fusion model called MSF-CPMP, which aims to increase the accuracy of predicted CPMP. The MSF-CPMP model incorporates three features extracted from SMILES sequences, graph-based molecular structures, and physicochemical properties of cyclic peptides. By benchmarking with other non-deep-learning and deep learning-based methods, MSF-CPMP achieved the highest levels of the evaluation metrics such as accuracy of 0.9062 and AUROC of 0.9546 and further validated MSF-CPMP robustness in learning capabilities and efficacy of its multi-source fusion. Our result demonstrates that MSF-CPMP outperforms other methods in predicting CPMP, that provides also exemplifies the power of advanced deep learning methods in tackling complex biological challenges, offering contributions to computational biology and clinical treatment. Code is available at https://github.com/wanglabhku/MSF-CPMP.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.